Page last updated: 2024-08-22

tabersonine and Lung Injury, Acute

tabersonine has been researched along with Lung Injury, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ding, Y; He, H; Hu, Y; Jiang, H; Li, X; Qian, F; Sun, L; Wu, Y; Xu, J; Yu, K; Zhang, D	1

Other Studies

1 other study(ies) available for tabersonine and Lung Injury, Acute

Article	Year
Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination. Biochemical pharmacology, 2018, Volume: 154 Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Indole Alkaloids; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Quinolines; Random Allocation; TNF Receptor-Associated Factor 6; Ubiquitination	2018

Article

Year

Tabersonine attenuates lipopolysaccharide-induced acute lung injury via suppressing TRAF6 ubiquitination.

Biochemical pharmacology, 2018, Volume: 154

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Indole Alkaloids; Inflammation Mediators; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Quinolines; Random Allocation; TNF Receptor-Associated Factor 6; Ubiquitination

2018